Skip to main content
Top

Arthritis Research & Therapy

Issue 6/2003

Content (14 Articles)

Open Access Research article

Mactinin: a modulator of the monocyte response to inflammation

Sharon D Luikart, Hollis E Krug, Robert D Nelson, Timothy Hinkel, Peter Majeski, Pankaj Gupta, Maren L Mahowald, Theodore Oegema

Open Access Research article

Differential gene expression in pristane-induced arthritis susceptible DA versus resistant E3 rats

Lena Wester, Dirk Koczan, Jens Holmberg, Peter Olofsson, Hans-Jürgen Thiesen, Rikard Holmdahl, Saleh Ibrahim

Open Access Research article

Impact of VIP and cAMP on the regulation of TNF-α and IL-10 production: implications for rheumatoid arthritis

Andrew D Foey, Sarah Field, Salman Ahmed, Abhilash Jain, Marc Feldmann, Fionula M Brennan, Richard Williams

Open Access Research article

HLA class II associations with rheumatic heart disease among clinically homogeneous patients in children in Latvia

Valda Stanevicha, Jelena Eglite, Arturs Sochnevs, Dace Gardovska, Dace Zavadska, Ruta Shantere

Review

Neural immune pathways and their connection to inflammatory diseases

Farideh Eskandari, Jeanette I Webster, Esther M Sternberg

Open Access Research article

Quantitative biomarker analysis of synovial gene expression by real-time PCR

David L Boyle, Sanna Rosengren, William Bugbee, Arthur Kavanaugh, Gary S Firestein

Open Access Research article

Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious

Ronald F van Vollenhoven, Sofia Ernestam, Anders Harju, Johan Bratt, Lars Klareskog

Review

Microarray analysis of gene expression in lupus

Mary K Crow, Jay Wohlgemuth

Viewpoint

Leukotrienes, mast cells, and T cells

Iain B McInnes

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine